Circular Genomics’ move to the Lilly Gateway Labs community will enhance scientific collaboration and innovation to foster the development of its Alzheimer’s disease diagnostic and prognostic blood ...

Company taps John R. Quain, Norbert Gleicher, MD, Carol Hanna, Ph.D, Jon Hennebold, Ph.D, and Stephen Turner, Ph.D to its world-class team to advance responsible genomic medicine. NEW YORK--(BUSINESS ...

New clinical data highlights circular RNAs (circRNAs) as a novel, non-invasive blood biomarker platform for the early detection of Alzheimer's Disease (AD). The research demonstrates that circRNAs ...

Researchers unveiled an automated, PCR-free whole genome sequencing library prep kit that combines advanced chemistry and digital fluidics to reduce bias, improve genome coverage, and deliver ...

Inherited diseases should not dictate human fate. Today, with advances in genomics, a different future is within reach. In this new era of genomic medicine, Manhattan Genomics, led by serial biotech ...